Arctic Therapeutics

Arctic Therapeutics's (AT) Dr. Ásbjörg Ósk Snorradóttir will be joining other leading researchers on the ground in #Munich for the 9th #InternationalCAAConference to discuss and share ideas, research and innovation on the role of #amyloid protein plaques in both rare and common forms of #dementia. The conference is the world's leading platform to exchange research and innovation, focused on treating and possibly preventing #CAA and related familial dementias, as well as the further underpinning the link to #Alzheimer's. For more information, see the comments.

Guðný Jónsdóttir and I had the privilege of attending Vísindavaka 2024 at Laugardalshöll yesterday where we presented Arctic Therapeutics projects. We had motivating and insightful conversations with so many passionate individuals, partners, and those affected by dementia and HCCAA (Hereditary Cerebral Amyloid Angiopathy). The discussions were not only motivating but gave us further drive to continue our work in these important fields. We also had the joy of interacting with young, curious minds — playing and teaching the kids about the structure of DNA was both fun and rewarding! 🧬 Their enthusiasm for science reminds us why education and outreach are so important. Thank you to everyone who took the time to connect and share insights. Thank you Silja Jóhannesar Ástudóttir for inviting us to tag along with Háskólinn á Akureyri and planning this event for all of us coming from Akureyri!

I am honored and grateful to have been invited as a speaker at the Maxwell User Meeting hosted by Promega Nordic in Gothenburg over the past two days. It’s an excellent opportunity to connect with other Maxwell users, share our experience at Arctic Therapeutics, share insights, and discuss the latest advancements in the field. A big thank you to Promega for organizing such a valuable platform for knowledge exchange and innovation. It was a pleasure to be part of such a vibrant and engaging community!

🌟 Collaboration in Action! 🌟 A couple of weeks ago a part of the #ArcticTherapeutics team had the opportunity to visit our collaborators at #Pharmarctica in Grenivík, north-Iceland. A huge thank you to the Pharmarctica team, especially Margrét Ösp Stefánsdóttir and Sigurbjörn Jakobsson, for the warm welcome and tour of your impressive new facilities. The visit was both educational and fun; highlighting the benefit and potential of our current and future collaboration with two of our frontrunners, AT-001 and AT-004. #Collaboration #Innovation #Pharma #Laboratory #Teamwork #AT001 #AT004

Iceland's president-elect Halla Tomasdottir visited our operations in #Akureyri on the campaign trail with her husband, Bjorn Skulason, taking the temperature of Iceland's thriving #startup and #innovation ecosystem across the country. Team Arctic Therapeutics would like to congratulate Halla Tomasdottir and wish her good luck in her new role as the President of Iceland. Sigridur Katrin Magnusdottir Olga Ýr Björgvinsdóttir Hekla Liv Maríasdóttir Hugrún Lísa Heimisdóttir Ivar Hakonarson Hakon Hakonarson Guðný Jónsdóttir

Thanks for coming to see us in #Iceland Vilma Radvilaite. Your guidance and the support of the #EUeic and the European Innovation Council and SMEs Executive Agency (EISMEA) is greatly appreciated on our journey to bring a safe and effective treatement to millions of patients with rare and common forms of #dementia - including #Alzheimer's.

We have enrolled our first patients into a registration study for our frontrunner AT-001 (NPI-001), following the green light from the European Medicines Agency, to bring a safe and effective treatment to patients with #HCCAA - a rare form of familial dementia. #HCCAA is a serious condition characterised by the accumulation of amyloid in the brain's blood vessels, which can lead to cerebral haemorrhage, stroke and progressive neurological deterioration. Our study aims to explore the potential of AT-001 in modifying the disease's course, improving patient outcomes, and ultimately, saving lives. We are grateful to our development partner, Nacuity Pharmaceuticals, Inc. - but our #strategicpartnership has allowed us to accelerate a treatment that holds the potential to prevent the onset of this form of #dementia and beyond.

🌐 Reflecting on an Eventful Week at Davos 🏔️ This past week at the World Economic Forum in Davos was nothing short of inspiring. It was a privilege to engage in insightful conversations and connect with global leaders who are at the forefront of transformative change. Special thanks the Merantix team - Hendrik Remigereau, Rasmus Rothe, and the European Innovation Council and SMEs Executive Agency (EISMEA) – Ekke Van Vliet, Thomas Ferré, Liviu Stirbat, and others, for hosting the AI House Davos venue and inviting us to join. Your hospitality made it the hub of innovation it was during the event! The roundtable discussion I took part in titled “Next-Gen Health: Navigating the AI revolution” was particularly enlightening, where discussions spanned from improving patient outcomes to transforming drug development and adapting the healthcare investment landscape in response to technological advancements. - Ashish Ipe Koshy of M42 Health - Ronald M. Razmi, MD of ZOI CAPITAL - Wei Li of BlackRock - Philippe GERWILL of AI 2030 - Tine Petric of Microsoft - Priv.- Doz. Dr. med. Lukas Martin, MHBA of Clinomic It was great to hear some real-world examples of how AI is already being implemented across various industries, within healthcare and beyond, which not only demonstrate the power of this technology but also its potential to make a tangible impact. For those interested, here is a link to an insightful panel discussion on how AI is transforming healthcare that took place during the week: https://lnkd.in/ea_UkRfa At Arctic Therapeutics, we remain committed to harnessing the potential of genomics, AI, and precision healthcare in drug development. Our mission is steadfast - to bring new and improved treatments to millions of patients worldwide. The insights gained at the World Economic Forum's Annual Meeting 2024 have only reinforced our resolve to leverage technology for the greater good. #WEF #Davos2024 #HealthcareInnovation #ArtificialIntelligence #Genomics #ArcticTherapeutics #DrugDevelopment #PrecisionHealthcare

Our co-founder and CEO Ivar Hakonarson joined the conversation at the AI House Davos, discussing the opportunities and challenges of applying #AI in healthcare - especially how it can be utilised to accelerate drug development and bring effective treatments to millions of patients. The #roundtablediscussion was hosted by M42 Health and moderated by COO Ashish Ipe Koshy. We look forward to moving the conversation forward with Ronald M. Razmi, MD, Wei Li, Philippe GERWILL & Tine Petric.

We are thrilled to be invited to attend the World Economic Forum's Annual Meeting in #Davos next week to shape the global conversation on how #AI can move healthcare forward, showcasing our pioneering approach to accelerate treatments for some of the most pressing health challenges. We are grateful for the support of the European Innovation Council and SMEs Executive Agency (EISMEA) and look forward to meeting other AI innovators at AI House Davos and beyond. Thanks for your continued support Vilma Radvilaite and Philipp Spenger. #Davos2024 #DrugDevelopment #ArcticTherapeutics #artificialintelligenceinhealthcare